12.28

4.25% 0.455

Carlsmed Inc (CARL)

Overview News Price History Discussions Forecast

Carlsmed Inc stock is traded at $12.28, with a volume of 13,580. It is up +4.25% in the last 24 hours and down -12.61% over the past month. Carlsmed Inc is a commercial-stage medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond. It is focused on becoming the standard of care for spine fusion surgery. The aprevo Technology Platform consists of AI-enabled software solutions, and interbody implants that it custom design for each patient's unique pathology and vertebral bone topography, and single-use surgical instruments. The Company designs, manufactures, and markets aprevo, a comprehensive technology platform for spine fusion surgery procedures.

Previous Close:

$11.82

Open:

$11.64

24h Volume:

13,580

Relative Volume:

0.15

Market Cap:

$325.76M

Revenue:

Net Income/Loss:

P/E Ratio:

EPS:

Net Cash Flow:

1W Performance:

-6.01%

1M Performance:

-12.61%

6M Performance:

+0.00%

1Y Performance:

+0.00%

1-Day Range:

$11.55

$12.28

1-Week Range:

$11.55

$13.20

52-Week Range:

$11.55

$16.20

Carlsmed Inc Stock (CARL) Company Profile

Name

Carlsmed Inc

Sector

Healthcare (1137)

Industry

Health Information Services (52)

Phone

858-295-9290

Address

1800 ASTON AVENUE, CARLSBAD

Employee

Twitter

Next Earnings Date

Latest SEC Filings

CARL's Discussions on Twitter

Compare CARL with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CARL Carlsmed Inc	12.25	314.33M	0	0	0	0.00
VEEV Veeva Systems Inc	242.57	44.34B	2.97B	809.93M	1.33B	4.8743
TEM Tempus Ai Inc	69.20	11.69B	803.32M	-709.10M	-212.68M	-7.8003
HQY Healthequity Inc	102.51	8.68B	1.15B	96.70M	-161.99M	1.09
DOCS Doximity Inc	50.30	8.74B	550.17M	201.35M	232.07M	1.00
WAY Waystar Holding Corp	35.66	6.66B	906.14M	-52.62M	89.62M	-0.3621

Carlsmed Inc Stock (CARL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-18-25	Initiated	BTIG Research	Buy
Aug-18-25	Initiated	BofA Securities	Buy
Aug-18-25	Initiated	Goldman	Buy
Aug-18-25	Initiated	Piper Sandler	Overweight
Aug-18-25	Initiated	Truist	Buy

Carlsmed Inc Stock (CARL) Latest News

Nov 19, 2025

Carlsmed, Inc. To Participate in the Piper Sandler 37th Annual Healthcare Conference - The Manila Times

Nov 19, 2025

Nov 16, 2025

Carlsmed (NASDAQ:CARL) Raised to Hold at Wall Street Zen - MarketBeat

Nov 16, 2025

Nov 11, 2025

Bioventus (NASDAQ:BVS) & Carlsmed (NASDAQ:CARL) Critical Contrast - Defense World

Nov 11, 2025

Nov 08, 2025

Truist Financial Reaffirms Buy Rating for Carlsmed (NASDAQ:CARL) - MarketBeat

Nov 08, 2025

BTIG Research Increases Carlsmed (NASDAQ:CARL) Price Target to $24.00 - MarketBeat

Nov 08, 2025

Nov 07, 2025

Carlsmed (NASDAQ:CARL) Announces Earnings Results, Beats Expectations By $0.05 EPS - MarketBeat

Nov 07, 2025

BTIG Maintains Carlsmed (CARL) Buy Recommendation - Nasdaq

Nov 07, 2025

Carlsmed stock price target raised to $24 by BTIG on strong Q3 results - Investing.com South Africa

Nov 07, 2025

Carlsmed Reports Third Quarter 2025 Financial Results and Raises Full-Year Guidance - The Manila Times

Nov 07, 2025

Earnings call transcript: Carlsmed Q3 2025 sees 98% revenue growth By Investing.com - Investing.com Nigeria

Nov 07, 2025

Carlsmed Reports Strong Q3 Growth and Raises Guidance - TipRanks

Nov 07, 2025

Nov 06, 2025

Earnings call transcript: Carlsmed Q3 2025 sees 98% revenue growth - Investing.com

Nov 06, 2025

Nov 02, 2025

Carlsmed Secures $60 Million Credit Facility Amendment - MSN

Nov 02, 2025